Summons from DGGI Mumbai under Section 70 of the CGST Act for GST verification
The company has received a Summons dated October 16, 2026, from DGGI, Mumbai Zonal Unit, under Section 70 of the Central GST Act, 2017.
By ScoutQuest · · 1 min read
- Summons Date
- Summons dated October 16, 2026
- Date Received
- received on October 23, 2026
- Issuing Authority and Provision
- DGGI, Mumbai Zonal Unit, under Section 70 of the Central Goods and Services Tax Act, 2017
What the company told the exchanges
The company has received a Summons dated October 16, 2026, which it received on October 23, 2026. It was issued under Section 70 of the Central Goods and Services Tax Act, 2017 by the Superintendent/Appraiser/Senior Intelligence Officer of the DGGI, Mumbai Zonal Unit.
- The summons is issued for verification of books of accounts.
- It is linked to GST compliance on re-imbursements made to foreign subsidiaries for clinical trials.
- The company states the summons does not specify any violations.
- The company says it is fully cooperating and will provide all necessary information.
What the company says about impact
The update states the summons does not have any material financial impact on the Company. In the annexure, the company says there is no material financial, operational or business impact at this stage.
What a summons under Section 70 means
- It is a power under the GST law used to call a person to give evidence or produce documents.
- It is a step in an inquiry, not a finding of wrongdoing. Penalties, demands or prosecution are separate outcomes, and nothing of that kind is set out here.
- The company says it will keep the stock exchanges informed of further significant developments, if any.
How to read this
The disclosure is about a tax-authority inquiry at the evidence-gathering stage, with the company's own assessment that the financial impact is not material. Investors may want to track follow-up disclosures for any change in that assessment, since the company has said it will report significant developments.
Also from Sahajanand Medical Technologies
Company Secretary & Compliance Officer appointment intimated to exchanges
23 Oct 2026
Company adopts code for fair disclosure of unpublished price sensitive information
23 Oct 2026
Three key managerial personnel authorised to decide materiality of events for exchange disclosure
23 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.